| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Aug―28 |
Exploring the Relationship Between Cannabis Use And COVID-19 Outcomes |
Chapman Wei, Nawal Mustafa, Radu Grovu, Fasih Sami Siddiqui, Umesh K. Manchandani, Saud Bin Abdul Sattar, et al. (+2) Waleed Sadiq, Ahmad Mustafa |
| 2 |
[GO] |
2023―Sep―15 |
Extracellular Vesicles and Endocannabinoid Signaling in Patients with COVID-19 |
Florian Brandes, Annekathrin M. Keiler, Benedikt Kirchner, Melanie Borrmann, Jean-Noël Billaud, Marlene Reithmair, et al. (+6) Matthias Klein, Patrizia Campolongo, Detlef Thieme, Michael W. Pfaffl, Gustav Schelling, Agnes S. Meidert |
| 3 |
[GO] |
2022―Oct―17 |
A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome |
Thomas P. Young, Joel S. Erickson, Shannon L. Hattan, Serge Guzy, Fabienne Hershkowitz, Michael D. Steward |
| 4 |
[GO] |
2022―Jul―26 |
Cannabidiol As a Treatment for COVID-19 Symptoms? A Critical Review |
Manuela Holst, Dennis Nowak, Eva Hoch |
| 5 |
[GO] |
2022―May―05 |
Cannabinoids as Emergent Therapy Against COVID-19 |
Joseph McGrail, Lucía Martín-Banderas, Matilde Durán-Lobato |
| 6 |
[GO] |
2022―Apr―01 |
Re: “Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial” by Crippa et al. |
Luis Vitetta, Tomas Andersen, Michelle Quezada, Dave Rutolo, Jeremy D. Henson |
| 7 |
[GO] |
2022―Jan―28 |
Endometriosis and Cannabis Consumption During the COVID-19 Pandemic: An International Cross-Sectional Survey |
Mike Armour, Justin Sinclair, Junipearl Cheng, Preston Davis, Aaish Hameed, Harini Meegahapola, et al. (+4) Krithika Rajashekar, Sunethra Suresh, Andrew Proudfoot, Mathew Leonardi |
| 8 |
[GO] |
2022―Jan―24 |
Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States |
Stephanie Lake, Ryan D. Assaf, Pamina M. Gorbach, Ziva D. Cooper |
| 9 |
[GO] |
2022―Jan―04 |
A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic |
Wendy Wing-Yee Chong, Zeynep Ilgaz Acar, Meghan Lee West, Francis Wong |
| 10 |
[GO] |
2021―Dec―17 |
Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment |
Aishwarya Saraswat, Richa Vartak, Manali Patki, Ketan Patel |
| 11 |
[GO] |
2021―Oct―09 |
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
José Alexandre S. Crippa, Julia Cozar Pacheco, Antonio W. Zuardi, Francisco S. Guimarães, Alline Cristina Campos, Flávia de Lima Osório, et al. (+25) Sonia Regina Loureiro, Rafael G. dos Santos, José Diogo S. Souza, Juliana Mayumi Ushirohira, Rafael Rinaldi Ferreira, Karla Cristinne Mancini Costa, Davi Silveira Scomparin, Franciele Franco Scarante, Isabela Pires-Dos-Santos, Raphael Mechoulam, Flávio Kapczinski, Benedito A.L. Fonseca, Danillo L.A. Esposito, Afonso Dinis Costa Passos, Amaury Lelis Dal Fabbro, Fernando Bellissimo-Rodrigues, Eurico Arruda, Sandro Scarpelini, Maristela Haddad Andraus, Julio Cesar Nather Junior, Danilo Tadao Wada, Marcel Koenigkam-Santos, Antonio Carlos Santos, Geraldo Busatto Filho, Jaime E.C. Hallak |
| 12 |
[GO] |
2020―Nov―09 |
Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders? |
Saoirse E. O'Sullivan, Carl W. Stevenson, Steven R. Laviolette |
| 13 |
[GO] |
2020―Aug―28 |
Letter to the Editor: Possible Drug-Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs |
M. Hunter Land, Laura MacNair, Brian F. Thomas, Erica N. Peters, Marcel O. Bonn-Miller |
| 14 |
[GO] |
2020―Apr―28 |
Cannabinoids and the Coronavirus |
Kevin P. Hill |
|
